-
MST1/2 Integrate Macrophage Death Signals
2026-08-13
Quagliato and colleagues identify MST1/2 cleavage as a flexible convergence point linking sterile inflammatory stimuli and bacterial infection to macrophage apoptosis. The study shows that macrophages can switch between MST1/2-associated apoptosis and GSDMD-mediated pyroptosis according to the stimulus and genetic context, providing a useful framework for interpreting cell-death phenotypes in infection and inflammation research.
-
Catalpol, Sirt6, and Osteoporosis: Study Analysis
2026-08-13
This study identifies the Sirt6–ERα–FasL axis as a mechanistic route through which catalpol promotes osteoclast apoptosis and mitigates estrogen deficiency–associated bone loss. Its combination of an ovariectomized rat model, RANKL-induced osteoclast assays, protein analysis, and Sirt6 knockdown provides a useful framework for evaluating mechanism-linked interventions in postmenopausal osteoporosis.
-
Small-Biopsy Dye Models in Surgical Pathology
2026-08-12
The reference study evaluated five dyes as pre-processing markers for small biopsy specimens and showed that merbromin, hematoxylin, and Alcian blue improved tissue visibility. Its main practical contribution is a workflow-level comparison demonstrating that hematoxylin offered the best balance of visibility, lower toxicity, and minimal interference with routine diagnostic assessment.
-
A23187, Free Acid: Calcium Ionophore Workflow
2026-08-12
A23187, free acid provides a controllable way to connect acute Ca2+ elevation with phosphoinositide signaling, oxidative stress, metabolic disruption, and cell death. This workflow emphasizes dose–time mapping and separates growth inhibition from true killing, enabling more interpretable in vitro response assays.
-
Small-Molecule Activators of Human ClpP: 2025 Review
2026-08-11
The 2025 Future Medicinal Chemistry review maps how small molecules activate or inhibit human mitochondrial ClpP, emphasizing imipridone-derived design, structure–activity relationships, and pharmacological evaluation. Its main implication is that controlled disruption of mitochondrial proteostasis may provide a distinct anticancer strategy, while selectivity, pharmacokinetics, and safety remain important translational barriers.
-
USP7–PKM2 Metabolic Control in Severe Acute Pancreatitis
2026-08-11
The 2025 Cell Death and Disease study identifies USP7 as a driver of pro-inflammatory macrophage polarization in severe acute pancreatitis through PKM2-dependent metabolic reprogramming. Its combination of genetic, metabolic, biochemical, and pharmacological evidence positions the USP7–PKM2 axis as a mechanistic framework for studying inflammatory macrophage function, while also defining important limits for therapeutic translation.
-
DIDS and the Biology of Surviving Cell Death
2026-08-10
DIDS is more than a chloride channel blocker: it is a useful experimental probe for separating ion transport, organelle injury, and prometastatic cell-state changes. This article connects DIDS mechanism, assay design, and the PAME findings reported in Cell Reports.
-
Baricitinib and Spatial Cytokine Signaling in PSC
2026-08-09
Baricitinib (LY3009104) can turn spatial proteomics observations in primary sclerosing cholangitis into testable JAK1/2 signaling experiments. This article presents a compartment-aware framework linking IL-6, IL-23, STAT3, and PD-L1 biology without overstating pharmacologic evidence.
-
Toremifene in Reliable Cell Assays
2026-08-08
This scenario-driven guide explains how Toremifene (SKU A3884) can support reproducible cell-growth and cytotoxicity workflows in prostate cancer and hormone-responsive cancer research. It connects the reported Toremifene IC50 of approximately 1 ± 0.3 μM in Ac-1 cells with practical guidance on solvent controls, stock handling, assay interpretation, and vendor selection.
-
Indomethacin Workflows for Inflammation Research
2026-08-07
Indomethacin provides a practical pharmacological comparator for COX-driven inflammation assays while also enabling PPARγ and membrane-organization studies. This workflow shows how to prepare, dose, control, and interpret the compound alongside the FXR–KLF11 findings reported in contrast-induced acute kidney injury research.
-
QX77: Molecular Chaperone Activator for Precision Autophagy
2026-08-07
QX77 empowers researchers to drive chaperone-mediated autophagy and stem cell differentiation with unmatched specificity by targeting LAMP2A and Rab11. This workflow-driven guide translates recent mechanistic insights and troubleshooting expertise into actionable protocols for advanced cellular studies.
-
Pexmetinib (ARRY-614): Dual Inhibition and Conformational Re
2026-08-06
Explore how Pexmetinib (ARRY-614) uniquely advances research on p38 MAPK and Tie2 pathways by combining dual kinase inhibition with conformational control of dephosphorylation. This article provides a new framework for leveraging ARRY-614's mechanistic depth in assay design and translational studies.
-
Dual-Network Hydrogel Microspheres Mitigate IVDD by Modulati
2026-08-06
This study introduces a multifunctional, elastic hydrogel microsphere system for targeted delivery of miR-155 to intervertebral disc cells, achieving inflammation modulation and apoptosis inhibition in intervertebral disc degeneration (IVDD). The platform's combined mechanical stability and stimulus-responsive drug release underscore its translational potential for restoring disc microenvironmental homeostasis.
-
Nitazoxanide Targets IMPA1-RAGE Axis in Pulmonary Hypertensi
2026-08-05
This study identifies nitazoxanide as a novel modulator of pulmonary vascular remodeling in pulmonary hypertension (PH) by directly targeting the IMPA1-RAGE signaling axis. The research demonstrates that nitazoxanide suppresses PASMC proliferation and glycolytic reprogramming, offering a mechanistically distinct approach to PH therapy.
-
Herbal Extracts Delay Danazol-Induced Precocious Puberty in
2026-08-05
This study demonstrates that a combined extract of Eclipta prostrata and Hordeum vulgare delays the onset of precocious puberty in rat models induced by Danazol and high-fat diet. By modulating the hypothalamic–pituitary–gonadal axis and attenuating GnRH mRNA upregulation, the herbal complex offers a promising, side-effect-sparing alternative for early puberty intervention.